Half-year report · Q2
7716.TEDINET S100WGNK
Period2025-01-01 → 2025-06-30
Filed2025-08-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥39.2bn | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Revenue | ¥77.0bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥38.6bn | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Operating income | ¥7.6bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Operating income | ¥8.3bn | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Ordinary income | ¥6.9bn | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥17.3bn | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥10.5bn | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥7.0bn | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥10.5bn | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.5bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥8.6bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥7.0bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.5bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Net income | ¥7.0bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Total assets | ¥153.8bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥158.3bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥156.8bn | at 2024-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥36.5bn | at 2025-06-30 | Cons. | Liabilities |
| Total liabilities | ¥37.1bn | at 2024-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥117.3bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥121.2bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥124.0bn | at 2024-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥46.6bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥46.1bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥32.7bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥35.2bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥30.1bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥26.0bn | at 2023-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥7.6bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥15.3bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥7.3bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥6.4bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥7.9bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.9bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.6bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥599m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.4bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥41.84 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥101.37 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥82.88 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥41.7 | 2025-01-01 → 2025-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥101.06 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥82.63 | 2024-01-01 → 2024-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 76.0% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.3% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.9% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 40
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥176m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥176m |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥2.8bn |
| jpcrp040300-q2r_E02331-000DCI Productsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥9.8bn |
| jpcrp040300-q2r_E02331-000DCI Productsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥9.8bn |
| jpcrp040300-q2r_E02331-000DCI Productsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥66m |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥23.7bn |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥23.5bn |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥176m |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥8.7bn |
| jpcrp040300-q2r_E02331-000Industrial Productsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥3.3bn |
| jpcrp040300-q2r_E02331-000Industrial Productsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥3.3bn |
| jpcrp040300-q2r_E02331-000Industrial Productsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥363m |
| jpcrp040300-q2r_E02331-000Surgical Productsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥2.5bn |
| jpcrp040300-q2r_E02331-000Surgical Productsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥2.5bn |
| jpcrp040300-q2r_E02331-000Surgical Productsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥1.3bn |
| —segment total | revenue | 2025-01-01 → 2025-06-30 | ¥39.4bn |
| —segment total | revenue external | 2025-01-01 → 2025-06-30 | ¥39.2bn |
| —segment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥176m |
| —segment total | segment profit | 2025-01-01 → 2025-06-30 | ¥10.4bn |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥126m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥126m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥2.8bn |
| jpcrp040300-q2r_E02331-000DCI Productsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥9.9bn |
| jpcrp040300-q2r_E02331-000DCI Productsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥9.9bn |
| jpcrp040300-q2r_E02331-000DCI Productsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥401m |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥23.5bn |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥23.3bn |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥126m |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥9.2bn |
| jpcrp040300-q2r_E02331-000Industrial Productsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥3.3bn |
| jpcrp040300-q2r_E02331-000Industrial Productsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥3.3bn |
| jpcrp040300-q2r_E02331-000Industrial Productsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥415m |
| jpcrp040300-q2r_E02331-000Surgical Productsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥2.0bn |
| jpcrp040300-q2r_E02331-000Surgical Productsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥2.0bn |
| jpcrp040300-q2r_E02331-000Surgical Productsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥1.1bn |
| —segment total | revenue | 2024-01-01 → 2024-06-30 | ¥38.7bn |
| —segment total | revenue external | 2024-01-01 → 2024-06-30 | ¥38.6bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥126m |
| —segment total | segment profit | 2024-01-01 → 2024-06-30 | ¥11.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 557
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 4530000 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.0543 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 4362000 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0523 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 3721000 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0446 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 3236000 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0388 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 3120000 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0374 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 2802000 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0336 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 2798000 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0335 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 2688000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0322 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 2265000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0271 | |
| Number of shares held | CurrentQuarterInstant | 34194000 | |
| Shareholding ratio | CurrentQuarterInstant | 0.4101 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 10041200 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 83340000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 833400 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 37000 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 93418200 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 833400 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 10041200 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 10041200 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.1075 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 10041200 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 10041200 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.1075 | |
| Cash and deposits | Prior1YearInstant | 46051104000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 46603347000 | JPY |
| Notes receivable trade | Prior1YearInstant | 138162000 | JPY |
| Notes receivable trade | CurrentQuarterInstant | 128189000 | JPY |
| Accounts receivable trade | Prior1YearInstant | 9358851000 | JPY |
| Accounts receivable trade | CurrentQuarterInstant | 9381903000 | JPY |
| Short term investment securities | Prior1YearInstant | 1060866000 | JPY |
| Short term investment securities | CurrentQuarterInstant | 1204309000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 12978197000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 12844478000 | JPY |
| Work in process | Prior1YearInstant | 5859091000 | JPY |
| Work in process | CurrentQuarterInstant | 5823034000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |